ODDB.org: Open Drug Database

Helvepharm AG - Lansoprazol Zentiva 15 mg, magensaftresistente Hartkapseln

Swissmedic Registration	57801	Sequence	01
Product name	Lansoprazol Zentiva 15 mg	Description	magensaftresistente Hartkapseln
ATC-Classification	A02BC03	ATC-Description	Lansoprazole
Introduction of Sequence	14.06.2007

Composition

lansoprazolum 15 mg, sacchari sphaerae cum saccharum max. 108.734 mg et maydis amylum, natrii laurilsulfas, megluminum, mannitolum, hypromellosum, macrogolum 6000, talcum, polysorbatum 80, E 171, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, Kapselhülle: gelatina, E 104, E 171, pro capsula corresp. natrium 0.00056 mg.

Packungsbestandteile

Galenic Form

Capsules

Excipiens

Active Agent	Dose
Lansoprazole	15 mg

BAG: Active Agent	Dose
Lansoprazole	15 mg

Inactive agents	Dose	additional_information
Acidi Methacrylici
E 104		color.
E 171		color.
Ethylis Acrylatis Polymerisatum Dispersio	30
Gelatina		Kapselhülle
Hypromellosum
Macrogol	6000
Mannitol
Maydis Amylum
Meglumine
Natrii Laurilsulfas
Per Centum
Polysorbatum 80
Sacchari Sphaerae cum Saccharum	108.734 mg
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	14	4.98	14.65	B	SL	No
003	28	9.92	27.20	B	SL	No
005	56	15.43	33.30	B	SL	No
007	112	28.47	47.45	B	SL	No
009	2 x 56			B		Yes

2025	©ywesee GmbH